Naharuthai Bumrungratanayos

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Clostridium Difficile

Top Venues

Annals of hematology

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

Songphol Tungjitviboonkun, Naharuthai Bumrungratanayos, Jedsadakorn Jitwimungsanon, Thanat Kheamakulvanich, Smuch Siramongkholkarn
Efficacy and safety of fostamatinib in refractory immune thrombocytopenia: a meta-analysis from randomized controlled trials. Annals of hematology (2024)
Songphol Tungjitviboonkun, Naharuthai Bumrungratanayos, Jedsadakorn Jitwimungsanon, Thanat Kheamakulvanich, Smuch Siramongkholkarn
Efficacy and safety of fostamatinib in refractory immune thrombocytopenia: a meta-analysis from randomized controlled trials. Annals of hematology 103 (9) (2024)
Songphol Tungjitviboonkun, Naharuthai Bumrungratanayos, Jedsadakorn Jitwimungsanon, Thanat Kheamakulvanich, Smuch Siramongkholkarn
Efficacy and safety of fostamatinib in refractory immune thrombocytopenia: a meta-analysis from randomized controlled trials. Annals of hematology 103 (9) (2024)
Songphol Tungjitviboonkun, Naharuthai Bumrungratanayos, Jedsadakorn Jitwimungsanon, Thanat Kheamakulvanich, Smuch Siramongkholkarn
Efficacy and safety of fostamatinib in refractory immune thrombocytopenia: a meta-analysis from randomized controlled trials. Annals of hematology 103 (9) (2024)
Songphol Tungjitviboonkun, Naharuthai Bumrungratanayos, Jedsadakorn Jitwimungsanon
Erlotinib-associated interstitial pneumonitis with successful readministration. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)